ULCERATIVE COLITIS (UC)

This study looks at patients with Crohn's disease or ulcerative colitis who are switching from receiving their vedolizumab medication through intravenous (IV) infusions at a clinic to giving themselves subcutaneous (SC) injections at home. Researchers will review the medical reco…

This study is testing whether the drug risankizumab can safely keep ulcerative colitis under control for a year or more in people who initially responded to it. It involves 1,242 participants who will receive either the drug or a placebo to compare results. The main goals are to …

This study aims to understand the long-term safety and effectiveness of the drug upadacitinib for adults with ulcerative colitis. It is for people who have already participated in related earlier studies, either because their condition did not improve enough or they lost their re…

This study is looking at whether adding a specific herbal supplement called CurQD helps people with active ulcerative colitis who are already taking the medication vedolizumab but still have symptoms. Researchers will review the health records of 400 patients to see if the combin…

This study is creating a large database of patients with Crohn's disease and ulcerative colitis. Researchers will use this information to build tools that can predict how severe a patient's disease might become and how well they will respond to specific medications. The goal is t…

This study aims to understand how inflammatory bowel diseases (IBD) like Crohn's and ulcerative colitis affect people's daily lives, well-being, and sense of disability. Researchers will survey 385 adult patients to learn what factors—like symptoms, social support, or personal be…